Abbott: Coronary Stenosis trials

The registry lists 25 Coronary Stenosis studies with Abbott as lead sponsor. 0 are open to participants now and 21 have results posted.

Phase 3 3Phase 4 5No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FUnctional diagnoSIs of corONary Stenosis (FUSION)CompletedNCT04356027Results posted
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)CompletedNCT03507777Not applicableResults posted
• Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery LesionsCompletedNCT02229864Not applicableResults posted
• Absorb IV Randomized Controlled TrialCompletedNCT02173379Not applicableResults posted
• A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)CompletedNCT01923740Not applicableResults posted
• ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.CompletedNCT01759290Results posted
• ABSORB III Randomized Controlled Trial (RCT)CompletedNCT01751906Not applicableResults posted
• XIENCE PRIME Japan Post-Marketing Surveillance (PMS)CompletedNCT01721096Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
• EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
• A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic LesionsCompletedNCT01186198Results posted
• XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)CompletedNCT01120379Results posted
• A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese PopulationCompletedNCT01115933Not applicableResults posted
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortCompletedNCT01106534Phase 4Results posted
• XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
• ABSORB EXTEND Clinical InvestigationCompletedNCT01023789Not applicableResults posted
• SPIRIT PRIME Clinical TrialCompletedNCT00916370Phase 3Results posted
• EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT00531011Phase 4Results posted
• SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)CompletedNCT00180479Phase 3Results posted
• EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT01310309
• EXCEL Clinical Trial (Universal Registry)CompletedNCT01205789
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
• SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180453Phase 3